This new publication proposes a review of global pharma trends by 2025 and an analysis of top 20 pharma companies’ performance and strategies
News
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...
In this new position paper, we propose a proven and straightforward methodology to help the management of...